Baldrige Asset Management’s Pfizer PFE Stock Holding History

Baldrige Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$46K	Sell	1,118 -384	-26%	-$16.6K	0.02%	181
2022 Q4	$77K	Hold	1,502	–	–	0.03%	153
2022 Q3	$66K	Hold	1,502	–	–	0.03%	155
2022 Q2	$79K	Hold	1,502	–	–	0.04%	148
2022 Q1	$78K	Sell	1,502 -110	-7%	-$5.71K	0.03%	151
2021 Q4	$95K	Sell	1,612 -121	-7%	-$6K	0.04%	138
2021 Q3	$75K	Sell	1,733 -121	-7%	-$5.36K	0.03%	144
2021 Q2	$73K	Buy	+1,854	New	+$72.1K	0.03%	145
2020 Q1	–	Sell	-2,088	Closed	-$78K	–	82
2019 Q4	$78K	Sell	2,088 -86	-4%	-$3.06K	0.06%	75
2019 Q3	$74K	Sell	2,174 -596	-22%	-$21.7K	0.07%	72
2019 Q2	$114K	Buy	2,770 +369	+15%	+$14.7K	0.11%	67
2019 Q1	$97K	Buy	+2,401	New	+$96.2K	0.09%	66

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baldrige Asset Management's PFE Position: Q1 2023 in Review

Baldrige Asset Management reduced its Pfizer (PFE) stake by 26% in Q1 2023, selling an estimated $16.6K and leaving 1,118 shares worth $46K. The position accounts for 0.02% of the portfolio, ranked #181.

Baldrige Asset Management first reported a position in PFE in Q1 2019 and has held it in 12 quarters since. The position peaked at $114K in Q2 2019. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Baldrige Asset Management held 1,118 shares of Pfizer worth $46K as of Q1 2023.
Baldrige Asset Management sold 384 Pfizer shares in Q1 2023, an estimated $16.6K.
Pfizer made up 0.02% of Baldrige Asset Management's portfolio in Q1 2023, its #181 holding.
Baldrige Asset Management first reported a position in Pfizer in Q1 2019 and has held it in 12 quarters since.
Baldrige Asset Management's Pfizer position peaked at $114K in Q2 2019.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.